Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Efficacy and Safety of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02041299
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:04.351023+00:00
Published At
2021-08-10T00:00:00+00:00
Record Updated At
2021-08-10
Results Posted At
2021-08-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Iron Overload", "Sickle Cell Disease", "Other Anemias"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-08-10"
protocolSection.identificationModule.nctId
"NCT02041299"
protocolSection.identificationModule.officialTitle
"The Efficacy and Safety of Ferriprox\u00ae for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-08-10"

Study condition terms

  • Iron Overload (protocolSection.conditionsModule.conditions)
  • Sickle Cell Disease (protocolSection.conditionsModule.conditions)
  • Other Anemias (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.